X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tideglusib (39) 39
index medicus (34) 34
humans (20) 20
alzheimers-disease (18) 18
progressive supranuclear palsy (17) 17
animals (11) 11
clinical neurology (11) 11
glycogen synthase kinase 3 - antagonists & inhibitors (11) 11
alzheimer's disease (10) 10
glycogen (10) 10
gsk-3 inhibitor tideglusib (9) 9
male (9) 9
neurosciences (9) 9
thiadiazoles - pharmacology (9) 9
biochemistry & molecular biology (8) 8
glycogen-synthase kinase-3-beta (8) 8
phosphorylation (8) 8
trial (8) 8
cell biology (7) 7
clinical trials (7) 7
disease (7) 7
female (7) 7
glycogen synthase kinase 3 (7) 7
glycogen synthase kinase 3 - metabolism (7) 7
glycogen-synthase kinase-3 (7) 7
gsk-3 (7) 7
kinases (7) 7
neurodegeneration (7) 7
tau (7) 7
mice (6) 6
neurodegenerative diseases (6) 6
synthesis (6) 6
thiadiazoles - therapeutic use (6) 6
aged (5) 5
apoptosis (5) 5
cancer (5) 5
diagnosis (5) 5
disorders (5) 5
double-blind method (5) 5
glycogen synthase kinase-3 (5) 5
health aspects (5) 5
lithium (5) 5
neurology (5) 5
pharmacology & pharmacy (5) 5
proteins (5) 5
research (5) 5
stem cells (5) 5
supranuclear palsy, progressive - drug therapy (5) 5
activation (4) 4
alzheimers disease (4) 4
analysis (4) 4
article (4) 4
cell cycle (4) 4
dementia (4) 4
dose-response relationship, drug (4) 4
expression (4) 4
gene expression (4) 4
genetic aspects (4) 4
gsk-3 inhibitors (4) 4
inhibitor tideglusib (4) 4
macromolecular substances (4) 4
middle aged (4) 4
oxidative stress (4) 4
pathology (4) 4
protein kinase inhibitors - pharmacology (4) 4
psp (4) 4
review (4) 4
structure-activity relationship (4) 4
treatment (4) 4
aged, 80 and over (3) 3
alzheimer disease - drug therapy (3) 3
apoptosis - drug effects (3) 3
beta-catenin (3) 3
biomarkers (3) 3
brain - pathology (3) 3
chemistry, medicinal (3) 3
chemistry, multidisciplinary (3) 3
cognitive impairment (3) 3
criteria (3) 3
davunetide (3) 3
enzyme inhibitors - pharmacology (3) 3
enzyme inhibitors - therapeutic use (3) 3
glycogen synthase kinase 3 beta (3) 3
glycogen synthase kinase-3 beta (3) 3
glycogen synthase kinase-3β (3) 3
gsk-3 inhibition (3) 3
in-vitro (3) 3
in-vivo (3) 3
inhibition (3) 3
inhibitors (3) 3
magnetic resonance imaging (3) 3
mental disorders (3) 3
mice, inbred c57bl (3) 3
molecular dynamics (3) 3
neurons (3) 3
oncology (3) 3
pharmacological treatment (3) 3
protein (3) 3
randomized controlled clinical trial (3) 3
reactive oxygen species - metabolism (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drug Research, ISSN 2194-9379, 08/2018, Volume 68, Issue 8, pp. 436 - 443
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 02/2019, Volume 18, Issue 2, pp. 257 - 266
Recently three different cyclin-dependent kinase 4 and 6 (CDK4/6) dual inhibitors were approved for the treatment of breast cancer (palbociclib, ribociclib,... 
BREAST-CANCER | PALBOCICLIB | STEM-CELLS | THERAPY | ONCOLOGY | WNT/BETA-CATENIN | LETROZOLE | DIFFERENTIATION | TIDEGLUSIB | ABEMACICLIB | COMBINATION
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 7, pp. 676 - 685
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2019, Volume 69, Issue 4, pp. 1031 - 1039
Background: The efficacy and safety of glycogen synthase kinase 3 (GSK-3) inhibitors in patients with Alzheimer's disease (AD) is unknown. Objective: A... 
Glycogen synthase kinase 3 | Lithium | Tideglusib | Alzheimer's disease | Meta-analysis | TARGET | TRIAL | lithium | meta-analysis | COGNITIVE IMPAIRMENT | NEURODEGENERATION | tideglusib | NEUROSCIENCES | glycogen synthase kinase 3 | LITHIUM TREATMENT
Journal Article
Movement Disorders, ISSN 0885-3185, 04/2014, Volume 29, Issue 4, pp. 470 - 478
Journal Article
Movement Disorders, ISSN 0885-3185, 04/2014, Volume 29, Issue 4, pp. 479 - 487
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 02/2018, Volume 339, pp. 57 - 65
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 01/2018, Volume 28, Issue 2, pp. 160 - 166
Glycogen synthase kinase-3β (GSK-3β) is an attractive therapeutic target for human diseases, such as diabetes, cancer, neurodegenerative diseases, and... 
Virtual screening | Molecular dynamics | GSK-3β | Radiometric assay | 2D similarity search | CHEMISTRY, MEDICINAL | GLYCOGEN-SYNTHASE KINASE-3 | LY2090314 | CHEMISTRY, ORGANIC | DISORDERS | PHASE-2 | TIDEGLUSIB | TRIAL | POTENT | BIOLOGICAL EVALUATION | GSK-3 beta
Journal Article
BBA - General Subjects, ISSN 0304-4165, 10/2016, Volume 1860, Issue 10, pp. 2076 - 2085
Hypoxia-ischemia is an important cause of brain injury and neurological morbidity in the newborn infants. The activity of glycogen synthase kinase-3β (GSK-3β)... 
GSK-3β | Neuroprotection | Tideglusib | Neonatal hypoxia–ischemia | Apoptosis | MOUSE-BRAIN | NEURONAL APOPTOSIS | ACTIVATION | Neonatal hypoxia-ischemia | BIOCHEMISTRY & MOLECULAR BIOLOGY | GSK-3 | GLYCOGEN-SYNTHASE KINASE-3-BETA | PERIINFARCT AREA | STROKE | BIOPHYSICS | SIGNALING PATHWAY | IN-VIVO | GSK-3 beta | CEREBRAL-ISCHEMIA
Journal Article